Market News Video
MNV MNV 10 Oversold Stocks You Need To Know About
Free Dividend Report - Top Ranked Stocks

Featured MNV Articles:

Exxon Mobil Takes Over #7 Spot From Johnson & Johnson
Tuesday, May 8, 4:36 PM ET, by Market News Video Staff

In the latest look at the underlying components of the S&P 500 ordered by largest ...

The New #11 Most Shorted Dow Component: Cisco Systems
Thursday, May 10, 10:39 AM ET, by Market News Video Staff

The most recent short interest data has been released for the 04/30/2018 settlement date, and ...

The New #10 Most Shorted Dow Component: Johnson & Johnson
Thursday, May 10, 10:42 AM ET, by Market News Video Staff

The most recent short interest data has been released for the 04/30/2018 settlement date, and ...

PPH Makes Bullish Cross Above Critical Moving Average
Friday, May 11, 4:29 PM ET, by Market News Video Staff

In trading on Friday, shares of the Pharmaceutical ETF (PPH) crossed above their 200 day ...

The Math Shows XRLV Can Go To $38
Monday, May 14, 9:11 AM ET, by Market News Video Staff

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, ...

Bullish Two Hundred Day Moving Average Cross - JNJ

By Market News Video Staff, Tuesday, September 27, 11:08 AM ET
Play Video: Learn About The 200 DMA

If the video does not load after a few moments, Upgrade to the Latest Flash Player.

In trading on Tuesday, shares of Johnson & Johnson (NYSE:JNJ) crossed above their 200 day moving average of $63.32, changing hands as high as $63.93 per share. Johnson & Johnson shares are currently trading up about 1.9% on the day. The chart below shows the one year performance of JNJ shares, versus its 200 day moving average:

Johnson & Johnson 200 Day Moving Average Chart

Looking at the chart above, JNJ's low point in its 52 week range is $57.50 per share, with $68.05 as the 52 week high point that compares with a last trade of $63.84.

According to the ETF Finder at ETF Channel, JNJ makes up 24.99% of the Pharmaceutical HOLDRS ETF (NASDAQ:PPH) which is trading up by about 1.7% on the day Tuesday.

See what other ETFs contain JNJ
See what other stocks are held by PPH

JNJ operates in the Drugs & Pharmaceuticals sector, among companies like Aegerion Pharmaceuticals Inc (AEGR) which is up about 0.5% today, and Avanir Pharmaceuticals, Inc. (AVNR) trading up by about 1.3%. Below is a three month price history chart comparing the stock performance of JNJ, versus AEGR and AVNR.

JNJ,AEGR,AVNR Relative Performance Chart


The ETF Channel Flexible Growth Investment Portfolio is designed to seek growth for investors anywhere and everywhere. The key to the program is our portfolio strategy allows us complete flexibility in terms of asset allocation as there are no predetermined guidelines as to the level of stocks, bonds, cash, regions, countries, sectors, commodities, or even asset classes in the portfolio! In short, this is a completely flexible portfolio designed to follow the performance trail wherever it leads us.

This Article's Word Cloud:   AEGR   AVNR   Above   According   Aegerion   Avanir   Average   Below   Channel   Crossing   Drugs   ETFs   Finder   Flexible   Free   Growth   Investment   Johnson   Looking   Moving   NYSE   Pharmaceutical   Pharmaceuticals   Portfolio   Start   Stocks   Their   Trial   Tuesday   about   above   asset   average   chart   designed   high   moving   other   performance   point   portfolio   share   shares   stocks   trading   versus   week   what   which   with
About Us - Advertise - Contact Us - Embedding Videos - Licensing Videos - Partners - mRSS / RSS Feed - Terms of Use - Privacy Policy
Home  |  Analyst News  Dividend Report  ETFs  Insider Report  Large Caps  Market Movers  Week Ahead Report  Weekly Market Wrap
MNV MNV Chart Zero Stock Market Game Stock Market Definitions

Bullish Two Hundred Day Moving Average Cross - JNJ | Market News Video | Copyright © 2008 - 2018, All Rights Reserved

Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners. In no way should any content contained herein be interpreted to represent trading or investment advice. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.